Menu
/REGISTER
Montecito
Giving Guide
Loading...
You are here:  Home  >  'Stellar Biotechnologies'  -  Page 3
Latest

Port Hueneme’s Stellar Biotechnologies posts mixed earnings results

By   /  Monday, February 8th, 2016  /  Central Coast Health Watch, Earnings, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Port Hueneme’s Stellar Biotechnologies posts mixed earnings results

Stellar Biotechnologies saw revenues increase 130 percent during the first quarter of 2016 but the company still lost more money in 2016 than it did during the same quarter of 2015. The Port Hueneme-based company reported first quarter 2016 results after markets closed Feb. 8. Stellar makes a protein for immunotherapy treatments using a unique Read More →

Read More →
Latest

Port Hueneme’s Stellar Biotechnologies trading on Nasdaq

By   /  Friday, November 6th, 2015  /  Latest news, Technology, Tri-County Public Companies, West Ventura County  /  Comments Off on Port Hueneme’s Stellar Biotechnologies trading on Nasdaq

Port Hueneme-based Stellar Biotechnologies started trading on the Nasdaq stock exchange Nov. 5. Stellar makes a protein for immunotherapy treatments using a unique sea snail only found off the coastal shores of a small part of California. Shares opened at $8.74 on Nov. 5 and were trading on the Nasdaq at $9.40 as of 11:30 Read More →

Read More →
Latest

Navy program at Port Hueneme taps area companies for new technology

By   /  Friday, July 10th, 2015  /  Latest news, Technology, Top Stories  /  Comments Off on Navy program at Port Hueneme taps area companies for new technology

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Stellar’s $12M raise sets stage for drug rollout

By   /  Friday, October 11th, 2013  /  Technology, Top Stories  /  Comments Off on Stellar’s $12M raise sets stage for drug rollout

Port Hueneme-based Stellar Biotechnologies has closed a $12 million round of financing and acquired a license for what could one day be its first drug. Stellar gained notoriety in the research world by snatching up a facility inside the Port of Hueneme gates during a round of base closings in the late 1990s. It used Read More →

Read More →